Prednimustine in advanced malignant melanoma: a phase II study.
Department of Oncology ONA, Finsen Institute, Rigshospitalet, Copenhagen, Denmark.
L
L
Pedersen
J
J
Løber
M
M
Dalmark
H T
HT
Mouridsen
D000328:Adult; D000368:Aged; D002699:Chlorambucil / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D011238:Prednimustine / Q000009:adverse effects / Q000627:therapeutic use*
D002699:Chlorambucil; D011238:Prednimustine